N-[3-Methyl-4-(2, 2, 2-trifluoroethoxy)-2-pyridinyl]methyl Lansoprazole-d4 13790 NAD+ precursor NMN treatment inhibited

NAD+ precursor NMN treatment inhibited CD8+ T cells activation and function

Chemical Name: methyl N-{1-[2-(5-{4'-[2-(1-{2-[(methoxycarbonyl)amino]-3-methylbutanoyl}pyrrolidin-2-yl)-1H-imidazol-5-yl]-[1

1-1 mg/kg i

ClH/c1-4-6-14-30(15-7-5-2)26(32)18-31-17-23(21-10-13-24-25(16-21)37-19-36-24)27(29(33)34)28(31)20-8-11-22(35-3)12-9-20

N-[3-Methyl-4-(2, 2, 2-trifluoroethoxy)-2-pyridinyl]methyl Lansoprazole-d4 13790 NAD+ precursor NMN treatment inhibitedProduct information CAS Number: 1794756 36 7 Molecular Weight: 576. 55 Formula: C25H22F6N4O3S Chemical Name: 2 {[3 methyl 4 (2,2,2 trifluoroethoxy)pyridin 2 yl]methanesulfinyl} 1 {[3 methyl 4 (2,2,2 trifluoroethoxy)pyridin 2 yl]methyl}(H) 1H 1,3 benzodiazole Smiles: [2H]C1C2=C(N=C(N2CC2=NC=CC(OCC(F)(F)F)=C2C)S(=O)CC2=NC=CC(OCC(F)(F)F)=C2C)C([2H])=C([2H])C=1[2H] InChiKey: GUWVDDXKNHBOLX LNFUJOGGSA N InChi: InChI=1S C25H22F6N4O3S c1 15 18(32 9 7